- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Sorrento Therape is a biotechnology business based in the US. Sorrento Therape shares (SRNE) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.00 – an increase of 7.69% over the previous week. Sorrento Therape employs 949 staff and has a trailing 12-month revenue of around $64.3 million.
What's in this guide?
Our top picks for where to buy Sorrento Therape stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Sorrento Therape stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SRNE. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Sorrento Therape stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Sorrento Therape stock price (NASDAQ: SRNE)
Use our graph to track the performance of SRNE stocks over time.Sorrento Therape shares at a glance
Latest market close | $0.00 |
---|---|
52-week range | $0.00 - $0.18 |
50-day moving average | $0.01 |
200-day moving average | $0.01 |
Wall St. target price | $13.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-1.83 |
Is it a good time to buy Sorrento Therape stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Sorrento Therape price performance over time
Historical closes compared with the close of $0.0036 from 2024-10-25
1 week (2024-10-22) | 38.46% |
---|---|
1 month (2024-09-27) | 33.33% |
3 months (2024-07-29) | -67.27% |
6 months (2024-04-25) | N/A |
1 year (2023-10-25) | N/A |
---|---|
2 years (2022-10-28) | -99.78% |
3 years (2021-10-29) | 6.86 |
5 years (2019-10-29) | 1.55 |
Sorrento Therape financials
Revenue TTM | $64.3 million |
---|---|
Gross profit TTM | $-167,049,000 |
Return on assets TTM | -40.82% |
Return on equity TTM | -378.92% |
Profit margin | 0% |
Book value | $-0.38 |
Market Capitalization | $1.2 million |
TTM: trailing 12 months
Sorrento Therape share dividends
We're not expecting Sorrento Therape to pay a dividend over the next 12 months.
Have Sorrento Therape's shares ever split?
Sorrento Therape's shares were split on a 1:25 basis on 31 July 2013 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sorrento Therape shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Sorrento Therape shares which in turn could have impacted Sorrento Therape's share price.
Sorrento Therape share price volatility
Over the last 12 months, Sorrento Therape's shares have ranged in value from as little as $0.0001 up to $0.182. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sorrento Therape's is 1.783. This would suggest that Sorrento Therape's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Sorrento Therape overview
Sorrento Therapeutics, Inc. , a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease,and pain. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis pain treatment; and ZTlido, a lidocaine topical system for the treatment of post-herpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia.
Frequently asked questions
nullWhat percentage of Sorrento Therape is owned by insiders or institutions?
Currently 0.89% of Sorrento Therape shares are held by insiders and 0.041% by institutions. How many people work for Sorrento Therape?
Latest data suggests 949 work at Sorrento Therape. When does the fiscal year end for Sorrento Therape?
Sorrento Therape's fiscal year ends in December. Where is Sorrento Therape based?
Sorrento Therape's address is: 4955 Directors Place, San Diego, CA, United States, 92121 What is Sorrento Therape's ISIN number?
Sorrento Therape's international securities identification number is: US83587F2020 What is Sorrento Therape's CUSIP number?
Sorrento Therape's Committee on Uniform Securities Identification Procedures number is: 74838K306
More guides on Finder
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
SoFi Invest® review 2024: Simple investing, free CFP access
SoFi Invest is a commission-free platform with both active and automated investment accounts.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
Ask a question